)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Arcellx (ACLX) investor relations material
Arcellx Status Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Status Update summary7 Dec, 2025
Efficacy and safety of anito-cel
Anito-cel demonstrated high efficacy in relapsed/refractory multiple myeloma, with a 96% overall response rate and 74% stringent complete response in phase 2, and durable responses up to six years in early patients.
Safety profile is highly favorable, with 95% of patients experiencing only grade 1 or no CRS, minimal ICANS, and no delayed neurotoxicities or secondary malignancies observed.
Sustained MRD negativity was achieved in 83% of patients at six months, and 24-month PFS and OS rates were 62% and 83%, respectively.
Manufacturing success rate was 99%, and the therapy is suitable for older and diverse patient populations.
Outpatient administration is feasible due to low toxicity, supporting broader adoption.
Differentiation from bispecifics and other CAR Ts
Anito-cel combines the efficacy and durability of CAR T with the safety and accessibility of bispecifics, offering low CRS/ICANS and broad scalability.
Bispecifics show higher infection rates, ICU admissions, and non-relapse mortality, with real-world efficacy and safety often inferior to clinical trial results.
Combination studies with Dara may inflate bispecific efficacy, but widespread frontline use of Dara limits real-world applicability.
Anito-cel is positioned as a category-defining therapy, with potential for mass adoption similar to disruptive innovations in other industries.
Commercialization and market opportunity
Commercial launch is imminent, with robust supply chain and manufacturing capacity through partnership with Kite, targeting up to 24,000 doses.
82% of authorized treatment centers have been engaged pre-approval, and strong support from payers, physicians, and advocacy groups is reported.
Market models project a $12B second-line+ and $20B+ frontline+ opportunity, with conservative class share assumptions for CAR T.
The company expects to overachieve these assumptions due to anito-cel's unique profile and disruptive potential.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Arcellx earnings date
Q4 202527 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Arcellx, Inc. is a clinical-stage biotechnology company focused on developing innovative cell therapies for the treatment of cancer and other severe diseases. The company's approach centers around engineering immunotherapies, particularly those based on CAR-T cell technology, to target specific cancers. Arcellx is headquartered in Redwood City, California, and its shares are listed on NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage